RSV was supposed to disappear by March. Instead, it's circulating at 3.2% positivity rates in April — triple the normal spring baseline. 47 states have now extended immunization programs through May 31, 2026, the largest coordinated RSV response in U.S. history.

Key Takeaways

  • 47 states extended RSV programs after April positivity hit 3.2% vs normal 1%
  • Southeast reporting 5%+ positivity rates — Children's Healthcare of Atlanta sees 18% RSV admissions
  • Extended season costs states $45 million additional, signals potential permanent pattern shift

The Pattern Break

The virus didn't get the memo about seasonal timing. CDC data shows RSV maintaining winter-level circulation well into spring — southeastern states are reporting positivity rates above 5% when they should be seeing near-zero transmission. Georgia, Alabama, and South Carolina lead the persistence, with clinical labs processing RSV-positive samples at rates typically reserved for December and January.

Dr. Sarah Chen at Children's Hospital of Philadelphia points to three factors: disrupted population immunity from pandemic isolation, increased social mixing, and potential viral evolution. The combination created what epidemiologists are calling a "seasonal drift" — RSV extending its circulation window beyond historical norms.

But the interesting part isn't the extended season itself. It's what it reveals about post-pandemic respiratory virus behavior.

a baby being examined by a doctor and nurse
Photo by CDC / Unsplash

The $45 Million Response

California, Texas, Florida, and New York announced extensions by March 28. 43 other states followed within ten days. Only Vermont, Wyoming, and Alaska held their original timelines — their transmission rates remained below 1.5%.

The extensions cost $45 million collectively, according to the Association of State and Territorial Health Officials. That's additional spending on Nirsevimab supplies, staffing, and logistics for programs designed to wind down by March. States are absorbing the costs rather than risk RSV hospitalizations in infants.

"This extension isn't just about following the virus — it's about protecting our most vulnerable populations when they need it most." — Dr. Maria Rodriguez, Chief Medical Officer, Texas Department of State Health Services

The speed of state coordination surprised public health observers. Typically, multi-state policy responses take months to organize.

Hospital Reality Check

Children's Healthcare of Atlanta reports 18% of respiratory admissions are RSV cases in early April — six times the 3% rate from April 2025. Houston's Texas Children's Hospital shows similar numbers. Phoenix Children's Hospital extended its RSV rapid testing protocols through June 2026.

The sustained season caught pediatric ICUs during their typical spring maintenance periods. Cook Children's Medical Center in Texas maintains winter-level staffing when they planned to scale back. Emergency departments that stored RSV testing supplies are reordering mid-season inventory.

Seattle Children's Hospital's Dr. Jennifer Park reports the monoclonal antibody maintains 79% efficacy against hospitalization regardless of administration timing. The immunization works the same in April as December — biology doesn't follow calendar seasons.

The Bigger Question

What most coverage misses: this isn't just about 2026. European countries saw similar RSV extensions in 2025, suggesting global respiratory virus seasonality is shifting permanently. Climate patterns, international travel, and post-pandemic immunity gaps are creating new circulation dynamics.

CDC epidemiologist Dr. Rochelle Wong frames it directly: respiratory viruses may no longer follow predictable seasonal patterns. The agency plans to revise surveillance protocols and potentially restructure immunization program timelines based on current data.

State health officials are developing "adaptive frameworks" — immunization programs that can extend or contract based on real-time transmission data rather than calendar dates. The approach acknowledges that post-pandemic virus behavior remains fundamentally unpredictable.

Either way, the era of assuming respiratory viruses follow neat seasonal schedules is ending. What replaces it will determine how prepared we are for the next pattern break.